Many countries in the Asia Pacific region have been promoting biotechnology as a promising industry, especially since the global electronics sector has slowed down. Governments in Malaysia, Singapore, Australia, India, South Korea, China, and Taiwan are creating and implementing pro-biotech policies to develop a strong domestic biotechnology hub with export capabilities. In each country, scientists and technology entrepreneurs have collaborated to form biotech-start-ups. Taiwan will have to design inventive growth tactics if it is to keep pace with its neighbors.

This Frost & Sullivan research service provides a comprehensive study of the status of the biotechnology industry in Taiwan. It identifies and discusses major market drivers and restraints, emerging technologies, and industry challenges; provides detailed market forecasts; and maps the relative competitive positions of countries in this region.

Government Support and Favorable Policies Drive Industry Growth

The Taiwanese Government is committed to building a complete biotechnology ecosystem in the country. Taiwans biotechnology industry was initiated with the launch of the Science and Technology Development Plan. "This plan specified biotechnology as one of the eight key technologies to be developed for the economic growth of the country," says the analyst of this research. "Since then, Taiwans biotechnology industry has evolved a complete supply chain capability including agribiotech, biochips, and biotechnology services."

However, biotech research in the Asia Pacific is largely conducted by government labs and universities and research activities are yet to achieve commercialization. Local biotech companies lack the required infrastructure to conduct and commercialize research. Collaborations with government research labs and universities are likely to provide the much needed impetus for the biotech industry.

Skilled Workforce and Collaborations Vital for the Next Stage of Industry Development

Despite the potential of several sectors in Taiwans biotech industry, the shortage of research and development (R&D) as well as human resources hinders the ambitious plans of the government. Due to issues such as the demand for technology transfer, there is increased focus on the recruitment of top-level managers and scientists, import of innovative research equipment, and partnerships with biotech-competent countries. The government has adopted a three-pronged strategy for developing the workforce base – it has started recruiting trained scientists from abroad, strengthening the education program, and relaxing the immigration policy for post-doctoral students.

International collaborations are also crucial for the development of the biotech industry. With accession to the World Trade Organization (WTO) in 2002, Taiwan has gained increased exposure to international practices such as the WTO dispute resolution procedures. Therefore, while biotech companies may face threats from overseas companies, they are also likely to gain greater foreign investment and trade. "Taiwanese enterprises can collaborate with European and U.S. companies and serve as local partners for clinical trials, technology development, and regional marketing," notes the analyst.

1 EXECUTIVE SUMMARY

Executive Summary: Executive Summary; Current State of Affairs; Revenue Forecasts of Taiwans Biotechnology Industry; Regional Competitive Benchmarking of the Biotechnology Industry; SWOT Analysis of Taiwan as a Biotech Hub; Key Success Factors; Take away Messages

2 OBJECTIVE AND CONSULTING METHODOLOGY

Objective and Consulting Methodology: Objective; Overall Industry Mapping Process; Research Methodology; Research Analysis Methodology

3 OVERVIEW OF TAIWAN BIOTECHNOLOGY INDUSTRY

Overview of Taiwan Biotechnology Industry: The Promised Land of the Biotechnology Market; Taiwans as a Top Biotechnology Hub; Tier Structures of Taiwan Biotechnology Industry; The Key Conduces of Taiwan Biotechnology Industry; SWOT Analysis of Taiwan as a Biotech Hub; The Overall Outlook for Taiwan Biotech

4 TAIWANS AGRICULTURAL BIOTECHNOLOGY

Taiwans Agricultural Biotechnology: The Strategic Value of Agricultural Biotech; Transgenics in a Nutshell; Value Chain Analysis of Transgenics; Herbal Medicine/Traditional Chinese Medicines

5 MEDICAL BIOTECHNOLOGY

Medical Biotechnology: Areas of Focus; Genomics & Proteomics; Vaccines; Cell Therapy

6 INDUSTRIAL BIOTECHNOLOGY

Industrial Biotechnology: Industrial Biotechnology

7 BIO SERVICES

Bio Services: Overview; Global Drivers for Bio-Services; Drug Discovery Contract Research in Taiwan; Key Industry Challenges; Value Chain Analysis

8 BIOTECH RELATED SECTORS

Biotech related Sectors: Areas of Focus; BioChip; Bioinformatics

9 REGIONAL COMPETITIVE BENCHMARKING

Regional Competitive Benchmarking: Regional Competitive Benchmarking; Singapore; South Korea; India; China; Malaysia

10 GROWTH STRATEGIES

Growth Strategies: Market Attractiveness of Biotechnology Industry in Taiwan; Government & Allied Bodies; Private Industry Participants; Key Success Factors; Conclusions

11 FROST & SULLIVAN AWARDS FOR THE TAIWAN BIOTECHNOLOGY INDUSTRY

Frost & Sullivan Awards for the Taiwan Biotechnology Industry: Frost & Sullivan Awards; Entrepreneurial Company Award-Contract Services; Growth Strategy Leadership Award - Biopharmaceuticals (Vaccines); Product Innovation Award - Transgenic Crops & Animal Products; Product Line Strategy Leadership Award - Biomaterials; Product Differentiation Innovation Award - Bioinformatics; Business Development Strategy Leadership Award - Cell Therapies; Technology Innovation Award - Microarrays

�@

簡介
目錄
相關商品

使用指南產品及服務須知網站導覽

星期一到星期五 / 9:30am - 6:00pm
TEL: 02-2729-4219 (+886-2-2729-4219)
E-mail: tw-info@gii.co.jp

台灣生物科技產業及與周邊國家的比較

Competitive Benchmarking of Taiwan Biotechnology Industry